ARTEMISMEDArtemis Medicare Services Limited
Other · · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, and inpatient and outpatient services. It also offers billing and insurance, childcare, emotional and support program, full body checkup, international patient, medical interpreter and record, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation program services, as well as home care services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on ARTEMISMED — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why buy
- • Profit growth: 46.7% YoY
- • Debt/Equity: 0.28
- • Promoter holding: 80.9%
- • RSI: 65
- • MACD: bullish
- • Price vs EMA21: above
Bull case
- • Profit growth: 46.7% YoY
- • Debt/Equity: 0.28
- • Promoter holding: 80.9%
- • RSI: 65
Bear case
- • Valuation vs sector: P/E 150.6 vs sector 25.5
- • PEG ratio: 3.23
- • Volume: 0.8x 20-day average
- • Sector momentum: sector -7.1% (1m)
Key risks
- • Valuation vs sector: P/E 150.6 vs sector 25.5
- • PEG ratio: 3.23
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹12.19). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.